Floatz logo

Therapeutic Asset Ratings

615 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Fluzoparib
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
hb1801
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Hetrombopag
Breast Cancer
Fudan UniversityP2CCC (48)
Hrs-1167
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Hrs-2189
Metastatic Malignant Neoplasm In The Colon
Fudan UniversityP2CCC (48)
Hrs-4508
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Hrs-4508
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
Hrs-6209
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Hrs-6209
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
ibi354
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Ivonescimab
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Ivonescimab
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
js207
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
js207
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
Jskn003
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
LENVATINIB
Solid Tumor, Adult
Fudan UniversityP2CCC (48)
LEUPROLIDE
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
Mitoxantrone
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Mitoxantrone
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
Narlumosbart
Non-Small Cell Lung Carcinoma
Fudan UniversityP2CCC (48)
Pyrotinib
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Raltitrexed
Colon Carcinoma
Fudan UniversityP2CCC (48)
Rimegepant
Colon Carcinoma
Fudan UniversityP2CCC (48)
Rivoceranib
HER2 Positive Breast Carcinoma
Fudan UniversityP2CCC (48)
Sacituzumab Tirumotecan
Her2-Receptor Negative Breast Cancer
Fudan UniversityP2CCC (48)
Showing 476 to 500 of 615 assets
PreviousPage 20 of 25Next